Stimulating natural killer cells to protect against cancer: recent developments
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stimulating natural killer cells to protect against cancer: recent developments
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 7, Issue 3, Pages 367-382
Publisher
Informa UK Limited
Online
2011-05-21
DOI
10.1586/eci.10.102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
- (2010) E. Lugli et al. BLOOD
- Synergism between immunostimulation and prevention of surgery-induced immune suppression: An approach to reduce post-operative tumor progression
- (2010) Roi Avraham et al. BRAIN BEHAVIOR AND IMMUNITY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Activity of Recombinant Human Interleukin-15 against Tumor Recurrence and Metastasis in Mice
- (2010) Feng Tang et al. Cellular & Molecular Immunology
- Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
- (2010) Véronique Decot et al. EXPERIMENTAL HEMATOLOGY
- Treatment of Hepatocellular Carcinoma with Adeno-Associated Virus Encoding Interleukin-15 Superagonist
- (2010) Chia-Ming Chang et al. HUMAN GENE THERAPY
- Characterization and IL-15 dependence of NK cells in humanized mice
- (2010) Elisabeth A. Pek et al. IMMUNOBIOLOGY
- Immune memory redefined: characterizing the longevity of natural killer cells
- (2010) Joseph C. Sun et al. IMMUNOLOGICAL REVIEWS
- TLR Stimulation of Prostate Tumor Cells Induces Chemokine-Mediated Recruitment of Specific Immune Cell Types
- (2010) R. Galli et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Thymic NK Cells Develop Independently from T Cell Precursors
- (2010) V. S. G. Ribeiro et al. JOURNAL OF IMMUNOLOGY
- Tumor Immunoediting by NKp46
- (2010) M. Elboim et al. JOURNAL OF IMMUNOLOGY
- Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility
- (2010) G. Solinas et al. JOURNAL OF IMMUNOLOGY
- Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses
- (2010) X. Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen
- (2010) D. B. Lowe et al. JOURNAL OF VIROLOGY
- FimH Can Directly Activate Human and Murine Natural Killer Cells via TLR4
- (2010) M Firoz Mian et al. MOLECULAR THERAPY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- IL-15R -IgG1-Fc Enhances IL-2 and IL-15 Anti-tumor Action through NK and CD8+ T Cells Proliferation and Activation
- (2010) Z. Wu et al. Journal of Molecular Cell Biology
- CpG Oligodeoxyneucleotides as TLR9 Agonists
- (2009) Yanal M. Murad et al. BIODRUGS
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma
- (2009) Jeffrey S. Weber et al. CANCER
- Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model
- (2009) Christian Ginzkey et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
- (2009) Tsukasa Seya et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
- (2009) Krystel Khawam et al. CANCER RESEARCH
- Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
- (2009) M. J. Szczepanski et al. CANCER RESEARCH
- IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice
- (2009) Jinxing Xia et al. CLINICAL IMMUNOLOGY
- Interleukin-22-Producing Natural Killer Cells and Lymphoid Tissue Inducer-like Cells in Mucosal Immunity
- (2009) Marco Colonna IMMUNITY
- Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas
- (2009) Camilla Rydberg et al. IMMUNOLOGY
- The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents
- (2009) Amani Makkouk et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
- (2009) G. Pietra et al. INTERNATIONAL IMMUNOLOGY
- Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
- (2009) Stephen McCartney et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
- (2009) M. B. Ahmed et al. JOURNAL OF IMMUNOLOGY
- A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4+CD25+ Regulatory T Cells and CD4+CD25- Responder T Cells
- (2009) M. Benito-Miguel et al. JOURNAL OF IMMUNOLOGY
- Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
- (2009) M. L. Salem et al. JOURNAL OF IMMUNOLOGY
- Dendritic Cells Support the In Vivo Development and Maintenance of NK Cells via IL-15 Trans-Presentation
- (2009) E. F. Castillo et al. JOURNAL OF IMMUNOLOGY
- IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
- (2009) S. Inoue et al. JOURNAL OF IMMUNOLOGY
- Poly I:C-Induced Activation of NK Cells by CD8 + Dendritic Cells via the IPS-1 and TRIF-Dependent Pathways
- (2009) T. Miyake et al. JOURNAL OF IMMUNOLOGY
- IFN-producing Killer Dendritic Cells Contribute to the Inhibitory Effect of Poly I:C on the Progression of Murine Melanoma
- (2009) Qun Jiang et al. JOURNAL OF IMMUNOTHERAPY
- Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN
- (2009) Michelandrea De Cesare et al. JOURNAL OF IMMUNOTHERAPY
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
- (2009) Binzhi Qian et al. PLoS One
- Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge
- (2009) Amanda Kwant-Mitchell et al. PLoS One
- Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
- (2009) M. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
- (2009) B. Jasani et al. VACCINE
- TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
- (2008) M MATSUMOTO et al. ADVANCED DRUG DELIVERY REVIEWS
- The IL-15 receptor chain cytoplasmic domain is critical for normal IL-15R function but is not required for trans-presentation
- (2008) Z. Wu et al. BLOOD
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
- (2008) Mehran Habibi et al. BREAST CANCER RESEARCH AND TREATMENT
- The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer
- (2008) C. Badoual et al. CANCER RESEARCH
- Interleukin-15/Interleukin-15R Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells
- (2008) M. Epardaud et al. CANCER RESEARCH
- Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
- (2008) D. L. Blum et al. CLINICAL CANCER RESEARCH
- Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis
- (2008) Z. Xiong et al. CLINICAL CANCER RESEARCH
- Natural killer cell immunotherapy for cancer: a new hope
- (2008) S. Srivastava et al. CYTOTHERAPY
- Efficacy of IL-2-versusIL-15-stimulated CD8 T cells in adoptive immunotherapy
- (2008) Katja Mueller et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Interleukin-15 stimulates macrophages to activate CD4+T cells: a role in the pathogenesis of rheumatoid arthritis?
- (2008) René Rückert et al. IMMUNOLOGY
- Natural killer cells: Detectors of stress
- (2008) Carmelo Luci et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation
- (2008) Erwan Mortier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients
- (2008) Julien Fourcade et al. JOURNAL OF IMMUNOTHERAPY
- A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas
- (2008) Nicholas Butowski et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
- (2008) Nicholas Butowski et al. JOURNAL OF NEURO-ONCOLOGY
- How a Cytokine Is Chaperoned through the Secretory Pathway by Complexing with Its Own Receptor: Lessons from Interleukin-15 (IL-15)/IL-15 Receptor
- (2008) E. H. Duitman et al. MOLECULAR AND CELLULAR BIOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Toll-like receptors and immune regulation: implications for cancer therapy
- (2008) R-F Wang et al. ONCOGENE
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor
- (2008) John Richards et al. PLoS One
- IL-15 as a mediator of CD4+help for CD8+T cell longevity and avoidance of TRAIL-mediated apoptosis
- (2008) SangKon Oh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity
- (2008) Uyen M. Le et al. RADIOTHERAPY AND ONCOLOGY
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
- A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
- (2008) H. Navabi et al. VACCINE
- FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling
- (2008) Ali A. Ashkar et al. PLoS Pathogens
- Macrophage activation and polarization
- (2007) Fernando Oneissi Martinez Frontiers in Bioscience-Landmark
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started